Healthcare -
Biotechnology - NASDAQ - US
$ 5.17
2.64 %
$ 461 M
Market Cap
-1.63
P/E
AMLX - OPERATING INCOME
Operating Income AMLX - Amylyx Pharmaceuticals, Inc.
-315 M
LAST VALUE
-25.03%
2 YEAR CAGR
-87.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR